Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
Running, not enrolling · Phase 3
Conditions studied: Non-small Cell Lung Cancer
In brief
The primary objective of this study is to compare the effect of zimberelimab (ZIM) and domvanalimab (DOM) in combination with chemotherapy relative to pembrolizumab (PEMBRO) in combination with chemotherapy on overall survival (OS) in patients with untreated metastatic non-small cell lung cancer with no actionable genomic alteration.
Key facts
- Study ID
- NCT05502237
- Run by
- Gilead Sciences
- People needed
- 1021
- Starts
- 2022-10-12
- Expected to finish
- 2029-01-01
- Last updated by the study team
- 2026-01-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- George Washington Medical Faculty Associates — Washington D.C., District of Columbia, United States
- Moffitt Cancer Center — Tampa, Florida, United States
- Illinois Cancer Care — Peoria, Illinois, United States
- Messino Cancer Centers — Asheville, North Carolina, United States
- Oncology Hematology Care, Inc. — Cincinnati, Ohio, United States
- Hematology & Oncology Associates — Eugene, Oregon, United States
- AHN Allegheny General Hospital — Pittsburgh, Pennsylvania, United States
- Texas Oncology - Austin — Austin, Texas, United States
- Oncology and Hematology Associates of Southwest Virginia, Inc — Blacksburg, Virginia, United States
- Northwest Cancer Specialists, PC — Vancouver, Washington, United States
- Investigaciones CORI S.R.L. — Capital, Argentina
- Centro Médico Privado Centro de Especialidades Médicas Ambulatorias e Investigación Clínica — Cardoba, Argentina
- Sanatorio Allende — Córdoba, Argentina
- Sanatorio Britanico de Rosario — Rosario, Argentina
- Sanatorio Parque de Rosario — Rosario, Argentina
- Hospital Provincial del Centenario — Rosario, Argentina
- Instituto Medico de la Fundacion Estudios Clinicos — Rosario, Argentina
- Clínica Viedma — Viedma, Argentina
- Ordensklinikum Linz GmbH, Elisabethinen — Linz, Austria
- Krankenhaus Nord - Klinik Floridsdorf — Vienna, Austria
- Klinikum Wels-Grieskirchen — Wels, Austria
- Algemeen Ziekenhuis Sint-Lucas — Aalst, Belgium
- Grand Hopital de Charleroi asbl (GHdC) — Charleroi, Belgium
- AZ Sint-Maarten — Mechelen, Belgium
- Innovative Clinical Research Institute — Whittier, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.